Updates
** Pfizer's PFE.N shares rise 4.4% to $24.06
** Stock set for its biggest single-day pct. jump in nearly 4 months, if gains hold
** PFE posts Q1 adj. EPS of $0.92, beating analysts' estimates of $0.67, according to data compiled by LSEG
** PFE's Q1 revenue misses estimates due to declining sales of its Paxlovid COVID-19 treatment, but co still sticks by FY revenue forecast of $61 billion-$64 billion
** Co says it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations
** Including session's moves, PFE has fallen about 10% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。